 HAUPPAUGE, N.Y., July 22, 2021 GLOBE NEWSWIRE -- Chembio Diagnostics, Inc. Nasdaq: CEMI, a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a 4 million purchase order from the Partnership for Supply Chain Management PFSCM, supported by The Global Fund, for the purchase of Chembios HIV 12 STAT-PAK Assay for shipment to Ethiopia into early 2022. Chembios delivery of the full number of tests covered by the purchase order may be affected by limitations of Chembios supply chain, staffing, and liquidity, and other matters outside Chembios control. 